Ipratropium Bromide Inhalation NDC 17270-0401

NDC codes

FDA NDC Directory

Product NDC (as listed)17270-0401Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17270-0401Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17270-0401-0	17270040100	1 CANISTER in 1 CARTON (17270-0401-0) / 200 AEROSOL in 1 CANISTERMarketed from Apr 16, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ipratropium Bromide Inhalation
Generic name (nonproprietary): ipratropium bromide inhalation
Active ingredients: Ipratropium bromide — 17 ug/1
Dosage form: Aerosol
Route: Respiratory (Inhalation)
Labeler: Armstrong Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217953
Marketing start: Apr 16, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 17270-0401_be83ceac-679d-42c3-960d-536709b5df99SPL ID be83ceac-679d-42c3-960d-536709b5df99SPL set ID 133cc2ed-f018-4295-b84e-b24382299360RxCUI 836343UNII J697UZ2A9J
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N417270040100 followed by a unit qualifier and the quantity

Package 17270-0401-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 16, 2026.

Indications (excerpt from the label)

Ipratropium bromide HFA inhalation aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Ipratropium bromide HFA inhalation aerosol is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)